Global AI in Mental Health Market Size and Forecast
The global AI in mental health market reached US$1.95 billion in 2024 and is expected to reach US$12.69 billion by 2033, growing at a CAGR of 22.8% during the forecast period 2025-2033, according to DataM Intelligence report.
The AI in the mental health market involves integrating advanced artificial intelligence technologies into mental health care to enhance diagnosis, treatment, and support services. This sector utilizes AI-powered tools such as chatbots, virtual therapists, and predictive analytics to make mental health interventions more accessible and effective.
Key drivers fueling this market include the rising prevalence of mental health conditions and the growing demand for telehealth expansion. There are significant opportunities in the AI in mental health market, particularly in the expansion of telemedicine and the advancement of AI-driven chatbots and virtual therapists.
Global AI in Mental Health Market - Executive Summary
Global AI in Mental Health Market Key Takeaways
- AI in mental health is expanding from consumer wellness applications into clinical workflows, provider platforms and payer environments.
- Machine learning remains a core technology, while NLP and generative AI provide significant future growth opportunities.
- AI-powered screening, virtual therapy, care navigation, clinical documentation and remote monitoring represent major application areas.
- Generative AI is creating new opportunities for conversational support, documentation and personalized behavioral interventions.
- Wearables, smartphones and voice analysis are expanding the amount of behavioral data available for AI-based assessment.
- Human-AI collaboration is likely to remain a major adoption model, particularly in clinical settings.
- Clinical validation is becoming a critical competitive differentiator for healthcare adoption.
- Privacy, cybersecurity, algorithmic bias and clinical safety remain major barriers to large-scale deployment.
- Reimbursement and enterprise partnerships can accelerate commercialization of clinically validated solutions.
- AI-powered clinical documentation represents an attractive B2B opportunity because it directly addresses provider workload.
- Remote monitoring and relapse prediction can expand AI applications beyond one-time assessment toward continuous care.
- North America remains a major market, while Asia-Pacific provides strong long-term growth potential.
- The competitive landscape is becoming more diverse, spanning conversational AI, voice analytics, assessment tools, digital therapeutics and integrated behavioral-health platforms.
Global AI in Mental Health Market - Scope
| Metrics | Details | |
| CAGR | 22.8% | |
| Market Size Available for Years | 2022-2033 | |
| Estimation Forecast Period | 2025-2033 | |
| Revenue Units | Value (US$ Bn) | |
| Segments Covered | Component | Software, Services |
| Technology | Machine Learning, Deep Learning, Natural Language Processing, Others | |
| Application | Anxiety, Depression, Schizophrenia, Post-Traumatic Stress Disorder (PTSD), Insomnia, Others | |
| End-User | Hospitals and Clinics, Mental Health Centers, Others | |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and the Middle East & Africa | |
Global AI in Mental Health Market Dynamics: Drivers
Increasing Prevalence of Mental Health Disorders
There has been a significant increase in the number of individuals diagnosed with mental health conditions such as anxiety, depression, and post-traumatic stress disorder (PTSD). In response to this growing need, AI technologies offer scalable solutions that can enhance access to mental health care and improve treatment outcomes.
Additionally, key players' strategies, such as partnerships & collaborations, and investments, would drive this AI in the mental health market. For instance, in October 2023, Ellipsis Health announced a strategic partnership with Augmedix, a healthcare technology company known for its ambient medical documentation solutions. This collaboration aims to integrate AI-driven mental health screenings into clinical encounters, significantly enhancing healthcare delivery by allowing providers to identify and address mental health issues earlier.
Global AI in Mental Health Market Dynamics: Restraints
Data Privacy and Security Concerns
One of the most significant challenges in the AI in mental health market is the management of sensitive patient information. AI systems rely on access to personal data to deliver accurate assessments and interventions, which raises important concerns regarding data privacy and the risk of security breaches.
Compliance with stringent regulations, such Health Insurance Portability and Accountability Act (HIPAA) in the U.S. and the General Data Protection Regulation (GDPR) in Europe, adds complexity to the implementation of AI solutions. Healthcare providers must ensure that robust data protection measures are established to safeguard patient information effectively.
According to data from A Vinove Company in 2024, significant privacy concerns arise when handling sensitive mental health information through AI chatbots. It is crucial to ensure that all interactions are encrypted and securely stored, in compliance with regulations such as GDPR and HIPAA. While chatbots can effectively provide support, they often struggle to fully understand the complexities of human emotions. This limitation can lead to misunderstandings or inadequate responses in more complex situations. Thus, the above factors could be limiting the global AI in the mental health market's potential growth.
For more details on this report - Request for Sample
Global AI in Mental Health Market - Segment Analysis
The global AI in mental health market is segmented based on component, technology, application, end-user, and region.
Component:
The software segment of the component is expected to hold 74.4% in the global AI in mental health market
AI-driven mental health software is increasingly being integrated into telehealth platforms, enabling users to easily access mental health professionals and resources. This integration facilitates remote consultations, making mental health care more convenient and accessible, especially for individuals in underserved areas.
AI in mental health rise of mobile applications allows users to engage with mental health resources anytime and anywhere. These apps often feature self-assessment tools, chatbots for immediate support, and personalized treatment plans, catering to a wide range of user needs. AI in mental health software utilizes advanced algorithms to analyze user data and provide tailored recommendations based on individual needs. This personalization enhances treatment effectiveness by addressing specific mental health concerns and preferences.
Additionally, key players in the industry's product launches would drive this global AI in mental health market growth. For instance, in October 2024, Manah launched a curated AI-based copilot designed to enhance mental well-being, marking a significant advancement in the field of mental health technology. This innovative solution aims to provide users with personalized support and resources to help them manage their mental health effectively.
Also, in April 2024, NextGen Healthcare announced the availability of its AI-driven ambient listening solution, NextGen Ambient Assist, specifically for psychiatrists and other prescribers in the behavioral health space. These factors have solidified the segment's position in the global AI in mental health market growth.
Global AI in Mental Health Market - Geographical Analysis
North America dominated the global AI in mental health market with the highest share of 42.3% in 2024
Top of Form
The rising incidence of mental health disorders drives the global AI in mental health market growth. According to the National Center for Biotechnology Information (NCBI) data in 2022, an estimated 59.3 million adults aged 18 and older in the United States experienced any mental illness (AMI), representing 23.1% of the total adult population.
The prevalence of AMI was notably higher among females, with 26.4% affected compared to 19.7% of males. Young adults aged 18 to 25 years exhibited the highest prevalence at 36.2%, followed by adults aged 26 to 49 years at 29.4%, and those aged 50 and older at 13.9%.
North America, particularly the United States, is leading the way in the adoption of AI technologies within the healthcare sector. The integration of AI into mental health services significantly improves diagnostic accuracy and treatment effectiveness, making it an appealing option for healthcare providers aiming to enhance patient outcomes.
Additionally, in this region, a major number of key players' presence, government initiatives & regulatory support, partnerships & collaborations, and product launches would propel the global AI in mental health market growth. For instance, in SAN FRANCISCO, in June 2024, Ellipsis Health partnered with Pega to innovate in the healthcare sector by developing AI-powered behavioral health solutions. This collaboration aims to enhance mental health services through advanced technology, leveraging AI to improve patient care and outcomes. This partnership focuses on utilizing AI to analyze vast amounts of behavioral health data.
Also, in November 2024, Jimini Health launched with $8 million in pre-seed funding, aiming to revolutionize mental health care through a unique AI-assisted therapy model. This New York-based startup combines the expertise of licensed clinicians with an AI therapist assistant named Sage to provide continuous, personalized support for patients. Thus, the above factors are consolidating the region's position as a dominant force in the global AI in mental health market.
Asia-Pacific region in the global AI in mental health market is expected to grow with the highest CAGR of 26-28% in the forecast period of 2025 to 2033
The increasing prevalence of mental health disorders, including depression, anxiety, and stress-related conditions, has created a substantial demand for effective AI in mental health services across the Asia Pacific countries.
According to the National Center for Biotechnology Information (NCBI) data in 2022, the prevalence of any mental illness (AMI) was highest among adults identifying as two or more races, at 35.2%, followed by White adults at 24.6%. In contrast, the prevalence of AMI was lowest among Asian adults, recorded at 16.8%. As awareness of these issues grows, there is an urgent need for accessible and efficient treatment options to address the rising burden of mental illness.
Countries such as China and India are heavily investing in AI technologies across various sectors, including healthcare. The integration of AI into mental health services enhances diagnostic capabilities and treatment options, making care more personalized and effective. This trend is supported by government initiatives aimed at fostering innovation in digital health solutions.
Rapid advancements in AI technologies, particularly in natural language processing (NLP) and machine learning, have led to the development of sophisticated tools that can analyze user interactions and provide tailored support. These technologies enable applications such as AI chatbots and virtual therapists to deliver real-time assistance, improving access to mental health care.
Furthermore, key players in the industry's product launches would drive this AI in the mental health market growth. For instance, in October 2024, the launch of Healo, an AI therapist developed by Infiheal, represents a significant advancement in mental health technology. Unveiled at the Bengaluru Tech Summit 2024, this innovative product aims to address global mental health challenges by providing accessible and affordable support. The event attracted notable tech leaders and government officials, including Prime Minister Narendra Modi, who praised Healo during his National Address.
Also, in April 2024, in New Delhi, Fortis Healthcare launched an innovative AI-powered mental healthcare app called Adayu, developed in collaboration with the deep-tech company United We Care. This initiative aims to enhance mental health support and accessibility for individuals seeking help. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global AI in mental health market.
Global AI in Mental Health Market - Competitive Landscape
The major global players in the AI in mental health market include Woebot Health, Wysa Ltd, BetterHelp, Lyra Health, Inc., Talkspace, Inc., Spring Care, Inc., Syra Health, Limbic, Ellipsis Health, Inc., and Aiberry, among others.
ealth Market -
Key Developments in the Global AI in Mental Health Market
- August 2026: Woebot Health continued advancing its digital mental-health platform, focusing on AI-supported behavioral health interventions and expanding access to evidence-based mental-health support.
- July 2026: Wysa Ltd. continued expanding its AI-powered mental-health support platform, with growing emphasis on employer and healthcare partnerships and personalized behavioral-health support.
- July 2026: BetterHelp continued strengthening its digital mental-health services, expanding access to licensed therapists while incorporating technology to improve patient-provider matching and engagement.
- June 2026: Lyra Health, Inc. continued expanding its technology-enabled behavioral-health platform, focusing on employer-sponsored mental-health services, personalized care pathways and improved access to behavioral healthcare.
- June 2026: Talkspace, Inc. continued expanding its digital mental-health platform and AI-supported capabilities, focusing on improving access, patient engagement and personalized behavioral-health services.
- May 2026: Spring Health continued expanding its technology-driven mental-health care platform, using data and intelligent matching capabilities to connect individuals with appropriate behavioral-health providers and treatment options.
- May 2026: Syra Health continued developing technology-enabled behavioral-health solutions, with emphasis on improving access, screening, care coordination and mental-health outcomes.
- April 2026: Limbic continued advancing AI-supported mental-health assessment and triage technologies, helping healthcare providers identify patient needs and streamline access to appropriate services.
- April 2026: Ellipsis Health, Inc. continued developing AI-enabled voice-based behavioral-health assessment technologies, supporting earlier identification and monitoring of mental-health conditions.
- April 2026: Aiberry continued developing AI-powered behavioral-health assessment tools, focusing on automated screening and clinical decision support for healthcare providers.
- In October 2024, MassMutual launched an innovative AI-powered mental health app called Wysa Assure, becoming the first U.S. insurer to offer such a service to its policyholders. This initiative is part of MassMutual's broader Health and Wellness Program, which aims to enhance the overall well-being of its clients by addressing both physical and mental health needs.
- In April 2024, in anticipation of World Health Day, themed "My Health, My Right," the World Health Organization (WHO) introduced S.A.R.A.H., an innovative digital health promoter prototype powered by generative artificial intelligence (AI). S.A.R.A.H., which stands for Smart AI Resource Assistant for Health, represents a significant advancement in AI-driven health information avatars, utilizing cutting-edge language models to enhance empathetic responses.
Why Choose DataM?
Technological Innovations: DataM evaluates advances in machine learning, deep learning, NLP, generative AI, predictive analytics, speech analysis, wearable integration, behavioral analytics and AI-enabled mental-health platforms.
Product Performance & Market Positioning: The report evaluates AI solutions based on screening accuracy, personalization, patient engagement, clinical workflow integration, scalability, interoperability, usability, data security and clinical validation.
Real-World Evidence: DataM connects market developments with AI applications across anxiety, depression, schizophrenia, PTSD, insomnia and other mental-health conditions while assessing real-world adoption across healthcare providers and consumers.
Market Updates & Industry Changes: The report tracks AI platform launches, clinical validation, healthcare partnerships, digital-health adoption, regulatory developments, privacy requirements, reimbursement trends and emerging generative-AI applications.
Competitive Strategies: DataM analyzes how leading companies strengthen their positions through specialized AI models, conversational platforms, voice analysis, clinical partnerships, provider networks, enterprise contracts and integration with digital-health ecosystems.
Pricing & Market Access: DataM evaluates market access based on software models, subscription structures, enterprise licensing, healthcare-provider contracts, reimbursement, clinical validation and implementation requirements.
Market Entry & Expansion: DataM identifies opportunities created by tele-mental health, mental-health professional shortages, wearable integration, remote monitoring, AI-enabled screening, clinical documentation, personalized care and expanding digital-health infrastructure in Asia-Pacific.
Target Audience
- AI & Digital Health Companies - Product and commercialization strategy.
- Mental Health Providers - Clinical workflow and technology adoption.
- Pharmaceutical & Biotech Companies - Digital therapeutic opportunities.
- Healthcare Payers - Reimbursement and cost analysis.
- Investors - AI mental-health market intelligence.
- Technology Providers - AI, NLP and data opportunities.
- Research Institutions - Clinical and technology development.
